During the past decade, Center for Women's Research conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Center for Women's Research" are "Fibrocystic Disease of Breast" (1 trials) and "Overactive Bladder" (1 trials). Many other conditions were trialed in "Center for Women's Research" in a lesser frequency.

Most popular intervention types in "Center for Women's Research" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Fesoterodine 4mg" (1 trials), "Fesoterodine 8mg" (1 trials) and "danazol" (1 trials). Other intervention names were less common.

The vast majority of trials in "Center for Women's Research" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Center for Women's Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Center for Women's Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Center for Women's Research, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".